CSTP-MO12 Course curriculum

Home Courses Completed Courses CSTP-MO12 Course curriculum

Session No.	Date	Title	Learning Objectives	Expert
	May 27, 2020	Pre-training & pre-module 1 quiz (sent through email, open until June 3, 3 pm)	To assess the current attitudes & practice with regard to cancer screening, & knowledge level regarding cervical cancer screening prevalent among the Medical Officers (MOs).
	June 03, 2020	Orientation (2:00-3:00 pm)	To orient the participants regarding the usage of Zoom and etiquettes of ECHO sessions.
1	June 03, 2020	Introduction to NICPR-ECHO’s online Cancer Screening course (2:30 to 3:00 pm) Introduction to Cancer Screening and the role of medical officers in the nations’ cancer screening program	Burden of cancer in India: Prevalence, incidence and mortality of cancer Causes of cancer Risk factors of cancer What is screening? Types of screening Risks and benefits of screening Introduction to cancer screening in India	Dr. Roopa Hariprasad, Scientist ‘E’, NICPR, Noida
MODULE 1: CERVICAL CANCER SCREENING
2	June 10, 2020	Methods of cervical cancer Screening and their advantage and disadvantages, Cervical Cancer Screening Guidelines in India and the rationale behind it (age, frequency, when to start, when to stop etc.)	Burden and natural history of cervical cancer Causes, risk factors, signs and symptoms of cervical cancer Anatomy & physiology of transformation zone and squamous columnar junction Screening tests and their pros and cons When to begin screening? For whom? Optimal screening intervals When to stop screening? Impact of HPV vaccination on future screening Operational Guidelines of MoHFW, India for cervical cancer screening	Dr. Kavitha Dhanasekaran,. Scientist ‘D’, NICPR, Noida
3	Jun 17, 2020	Visual Inspection with Acetic Acid (VIA) & its Evaluation	Brief Anatomy & Physiology of transformation Zone Principle of VIA Brief Step-by-step procedure of VIA with video, including the preparation of 5% acetic acid Interpretations of VIA in brief Briefly discuss the advantages and limitations of VIA	Dr. Roopa Hariprasad, Scientist ‘E’, NICPR, Noida
4	Jun 24, 2020	Treatment of CIN and Screen Positives	Types of ablative therapies (cryotherapy & thermocoagulation, including videos) Eligibility Contraindications Complications Follow up Types of excisional methods Eligibility criteria for treatment with excisional methods Follow up	Dr. Kavitha Dhanasekaran,. Scientist ‘D’, NICPR, Noida
5	July 01, 2020	Case Scenarios in Cervical Cancer Screening and Management Post-module 1 evaluation quiz (sent through email, open until July 08, 3 pm) Pre-module 2 evaluation quiz (sent through email, open until July 08, 3 pm)	Various cases pertaining to precancerous and cancerous cervical lesions will be discussed here. (VIA +ve, VIA -ve, Screen-and-treat cases etc.) To assess the knowledge level of MOs with regard to cervical cancer screening after the training module To assess the current knowledge level of MOs with regard to breast cancer screening.	Dr. Roopa Hariprasad, Scientist ‘E’, NICPR, NOida
MODULE 2: BREAST CANCER SCREENING
6	July 08, 2020	Introduction to Breast Cancer Screening, SBE & CBE	Burden of breast cancer Causes of breast cancer Risk factors Symptoms and signs of breast cancer Screening methods Operational guidelines of MoHFW, India for breast cancer screening Role of follow up and referral in reducing the burden of cancer	Dr. Anurag Shrivastava, Prof & Head, Dept of Surgery, AIIMS, New Delhi
7	July 15, 2020	Triple Assessment for Breast Cancer Screening	Types of diagnostic modalities available for breast cancer screening (triple assessment) Ultrasound: eligibility, advantages and limitations Mammography: eligibility, advantages and limitations MRI: eligibility, advantages and limitations FNAC/ Biopsy	Dr. Chitresh Kumar, Asst. Prof, NCI, Jajjar
8	July 22, 2020	Case scenarios pertaining to breast cancer screening Post-module 2 evaluation quiz (sent through email, open until July 29, 3 pm) Pre-module 3 evaluation quiz (sent through email, open until July 29, 3 pm)	Various cases pertaining to premalignant and malignant breast lesions will be discussed here. To assess the knowledge level of MOs with regard to breast cancer screening after the training module. To assess the current knowledge level of MOs with regard to oral cancer screening (& tobacco cessation).	Dr. Jnaneshwari, AIIMS New Delhi
MODULE 3: ORAL CANCER SCREENING & MISCELLANEOUS
9	July 29, 2020	Introduction to Oral Cancer Screening and its risk factors	Burden of Oral cancer Prevalence, incidence and mortality of oral cancer Causes, signs and symptoms, Risk factors Role of tobacco in oral cancer Common sites of oral cancer	Dr. Suzanne, NICPR, Noida
10	Aug 05, 2020	Common abnormalities of the oral cavity	Oral Visual examination (including extraoral examination) Oral potentially malignant disorders (OPMDs): old & new nomenclature Common OPMDs & other tobacco-related lesions: Leukoplakia, Erythroplakia, Oral Submucous Fibrosis, Oral Lichen Planus, Lichenoid Lesion, Smoker’s Palate, Tobacco Pouch keratosis Management of OPMDs Oral cancer: clinical features, TNM staging, an overview of management Common diagnostic adjuncts & Biopsy	Dr. Shalini Gupta, Asst. Prof, CDER-AIIMS, New Delhi
11	Aug 12, 2020	Tobacco Cessation: Counselling and follow up	Behavioural intervention Pharmacological intervention (with focus on NRT) Relapse and lapse Tobacco cessation clinic – a brief Target population m-Health – a brief	Dr. Bhavya Bairy, Asst. Prof, NIMHANS, Bengaluru
12	Aug 19, 2020	Infection Control	Disinfection of equipment Preparation of disinfectants or 0.5% hypocholorite solution, Sterilization of cancer screening equipment and disposal of used items	Dr. Rashmi Asif, Consultant, Ghaziabad
13	August 26, 2020	Breaking the news of screen positivity/ cancer	How to break the news of screen positive news How to calm down the situation in case of adverse response to the diagnosis	Dr. Apala Baduni, Palliative Care Physician, Can Support, Delhi
14	Sep 02, 2020	Documenting Cancer Screening Results	The various fields in the proforma for cancer screening Who fills it, how often What is the rationale and purpose behind each field	Sunita Nadhamuni/ Sruti EMC/Dell, Bengaluru
14	Sep 02, 2020	Post-training & post-module 3 evaluation quiz (sent through email, open until Sept 9, 3 pm)	To assess the knowledge level of MOs with regard to oral cancer screening & other important miscellaneous topics, & their attitudes & practice of cancer screening after the training module.

ELIGIBILITY CRITERIA FOR COURSE COMPLETION CERTIFICATE:

Attend atleast 10 out of total 14 sessions
Atleast 1 case presentation (on cervical, breast or oral cancer screening)
Minimum 50% in each module’s post quizzes, and 80% overall aggregate
Complete both pre and post training evaluation surveys.